Novel Agents for Treatment of High-risk COVID-19 Positive Patients
Condition(s):COVID; Sars-CoV2Last Updated:January 20, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):COVID; Sars-CoV2Last Updated:January 20, 2022Terminated
Condition(s):Covid19; PneumoniaLast Updated:March 17, 2021Unknown status
Condition(s):Covid19Last Updated:February 14, 2024Active, not recruiting
Condition(s):Covid-19Last Updated:October 19, 2020Completed
Condition(s):Covid19Last Updated:August 9, 2022Active, not recruiting
Condition(s):RosaceaLast Updated:June 9, 2023Recruiting
Condition(s):Onchocerciasis; EpilepsyLast Updated:November 28, 2023Completed
Condition(s):Scabies; Head LiceLast Updated:June 14, 2019Completed
Condition(s):Tuberculosis; Malnutrition; Helminth InfectionLast Updated:September 14, 2023Active, not recruiting
Condition(s):OnchocerciasisLast Updated:May 10, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.